Target intelligence / Profile preview

DCTN1 antisense RNA 1 (DCTN1-AS1)

Target: DCTN1-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

DCTN1 antisense RNA 1 (DCTN1-AS1) is a lncRNA transcribed in the antisense orientation to the DCTN1 gene. DCTN1-AS1 is a non-protein coding RNA and may be involved in the regulation of DCTN1 expression through epigenetic and transcriptional mechanisms[2][4][6]. DCTN1 has critical cellular functions in microtubule stability and axonal transport, and disruption is implicated in neurodegeneration (particularly in ALS and Alzheimer's disease)[2][4][1]. DCTN1-AS1, by antisense interactions, may modulate DCTN1 expression and thus indirectly influence pathways involved in tau pathology and neuronal integrity[2]. Changes in DCTN1-AS1 levels are observed in some neurodegenerative conditions, but its precise molecular function remains uncertain[2][4]. No drugs are currently known to target DCTN1-AS1 directly, and its use as a biomarker or therapeutic target is investigational.

Other names: DCTN1-AS1DCTN1 antisense RNA 1 (non-protein coding)

Mechanism of action

None known (no drugs identified that directly target DCTN1-AS1; potential use of antisense oligonucleotides for functional manipulation is speculative)

Biological functions

Regulation of gene expression (especially DCTN1, via antisense interaction)Epigenetic modulation (potential chromatin modification)Possible modulation of RNA stability, splicing, nuclear export

Disease associations

Neurodegenerative disease (e.g., Alzheimer’s disease, ALS via impact on DCTN1)Neurocognitive impairment (HIV-associated studies suggest correlation)

Safety considerations

None established; therapeutic challenges relate to targeting lncRNAs in general (off-target effects, tissue specificity, delivery)

Biomarkers

Decreased DCTN1-AS1 expression in Alzheimer's disease brain tissue

Beyond the preview

Go deeper on DCTN1 antisense RNA 1 (DCTN1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DCTN1 antisense RNA 1 (DCTN1-AS1).

Explore the full profile